Log in or Sign up for Free to view tailored content for your specialty!
Neurorehabilitation News
ED visits for seizures, epilepsy decreased during pandemic, especially in young children
Seizure- and epilepsy-related emergency department visits decreased during the COVID-19 pandemic compared with pre-pandemic levels, with the largest drop seen among young children, per a study in MMWR.
FDA grants priority review for Friedreich’s ataxia treatment
The FDA has granted priority review to Reata Pharmaceuticals Inc.’s new drug application for omaveloxolone to treat patients with Friedreich’s ataxia.
Log in or Sign up for Free to view tailored content for your specialty!
No improvement in memory, biomarkers with spermidine supplement compared with placebo
Long-term supplementation with spermidine improved neither memory function nor biomarkers compared with placebo in older adults with subjective cognitive decline, according to results of a clinical trial published in JAMA Network Open.
NIH awards $12 million to fund clinical trials for AD vaccine
Biotech company PharmaJet announced that its partner, the Institute for Molecular Medicine, was awarded a $12 million grant from the NIH National Institute on Aging for a vaccine to prevent Alzheimer’s disease.
Young stroke survivors with seizures at higher risk for dementia
Onset of seizures after stroke more than doubled the risk for dementia in young patients, according to a study published in Neurology.
Lacosamide safe, effective for childhood epilepsy with centrotemporal spikes
Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes was well tolerated and resulted in significantly reduced seizures, according to a study published in Brain and Development.
AbbVie submits NDA for advanced Parkinson’s treatment
Biopharmaceutical company AbbVie has submitted a new drug application to the FDA for ABBV-951, a 24-hour subcutaneous treatment for motor fluctuations in patients with advanced Parkinson's disease.
Many neurobiological factors determine changes of adaptive behavior in autism
Variation in clinical outcome is linked with both group- and individual-level variation in anatomy of cortical regions enriched for genes relevant to autism spectrum disorder, according to a study published in the American Journal of Psychiatry.
Neuropsychiatric sequelae of COVID-19 similar to other respiratory infections
Patients hospitalized for COVID-19 infection and those who survived other severe acute respiratory infections were at similarly higher risk for subsequent neuropsychiatric diagnoses and treatment, researchers reported in JAMA Psychiatry.
Cybin, Kernel announce positive results from neuroimaging technology pilot study
Neurotechnology firm Kernel and biopharmaceutical company Cybin announced promising pilot results from a feasibility study of Kernel Flow, a technology that measures brain activity in altered states of consciousness.